VIB-KULEUVEN Center for Cancer Biology
August 21 2017
Position Type
Full Time
Organization Type

We are currently seeking a highly motivated group leader with expertise and outstanding track record in cancer immunology with a preferable focus on the adaptive immune system and interest to implement novel immunotherapeutic strategies

The candidate will introduce cutting-edge technologies and experimental model systems in the field of immuno-oncology at VIB-KU Leuven. The candidate will be expected to develop ground-breaking scientific programs addressing fundamental research questions and should be interested in seeking opportunities to translate her/his findings into potential industrial applications and/or clinical benefit for patients.

The candidate needs to hold a PhD and provide a record of scientific excellence through high profile publications and acquisition of competitive funding. A collaborative and interdisciplinary mindset and experience in coaching and mentoring are highly valued assets.


We offer:

  • A challenging position in a supportive and international research environment with committed peers (this includes a mentoring program and a Group Leader coaching track)

  • An employment package that is attractive internationally and that is independent of research funding and grants

  • Substantial core research funding (€1.25M to €1.5M), renewable every 5 years

  • Access to top-notch core facilities including single cell genomics and bioinformatics, metabolomics, next generation sequencing, mouse genomic engineering and animal housing, histopathology, light and electron microscopy, FACS.

  • Collaborative atmosphere with clinicians from the University Hospital UZ Leuven located on the same campus.

  • Assistance with daily life issues such as relocation including visa application (if necessary), move & housing, school & day care

VIB is an equal opportunity employer promoting an inclusive environment in which everyone is respected.

Start date: in the course of 2018

This job comes from a partnership with Science Magazine and Euraxess